Scientists train Patients' own cells to hunt advanced breast cancer
NCT ID NCT05989828
Summary
This early-stage trial is testing a new treatment for advanced triple-negative breast cancer that has come back or stopped responding to standard therapies. Doctors take a patient's own immune cells, modify them in a lab to recognize and attack cancer cells, and then infuse them back into the patient. The main goals are to find a safe dose and understand the side effects of this personalized cell therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.